Amadori albumin in type 1 diabetic patients: Correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries

Diabetes

Volumn 48, Issue 12, 1999, Pages 2446-2453

  Schalkwijk, Casper G ^a   Ligtvoet, Nicole ^a   Twaalfhoven, Harry ^a   Jager, Agnes ^a   Blaauwgeers, Harriët G T ^b   Schlingemann, Reinier O ^b   Tarnow, Lise ^d   Parving, Hans Henrik ^d   Stehouwer, Coen D A ^a   Van Hinsbergh, Victor W M ^a,c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c TNO   (Netherlands)

^d STENO DIABETES CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DIAGNOSTIC VALUE; GLYCATION; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RETINA CAPILLARY;

EID: 0033512695     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.12.2446     Document Type: Article

References (39)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
2. Vlassara H, Bucala R, Striker L: Biology of disease: pathogenic effects of advanced glycosylation. biochemical, biologic and clinical implications for diabetes and aging. Lab Invest 70:138-151, 1994
3. Sell DR, Monnier VW: Structural elucidation of a senescence cross-link from human extracellular matrix. J Biol Chem 264:21597-21602, 1989
4. Reddy S, Bichler J, Wells-Knecht KJ, Thorpe SR, Baynes JW: N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry 34:10872-10878, 1995
5. Vlassara H, Striker L, Teichberg S, Fuh H, Li Y-M, Steffes M: Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats. Proc Natl Acad Sci U S A 91:11704-11708, 1994
6. Esposito C, Gerlach H, Brett J, Stern D, Vlassara H: Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med 170:1387-1407, 1989
7. Vlassara H, Fuh H, Donnelly T, Cybulsky M: Advanced glycation endproducts promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits. Mol Med 447-456, 1995
8. Schmidt AM, Hori O, Chen J-X, Li J-F, Crandall J, Zhang J, Cao R, Yan S-D, Brett J, Stern D: Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 in cultured human endothelial cells and in mice. J Clin Invest 96:1395-1403, 1996
9. Bucala R, Tracey KJ, Cerami A: Advanced glycation products quench nitric oxide and mediate defective endothelium-dependent vasodilation in experimental diabetes. J Clin Invest 87:432-438, 1991
10. Beisswenger PJ, Makita Z, Curphey TJ, Moore L, Jean S, Brinck-Johnsen T, Bucala R, Vlassara H: Formation of immunochemical advanced glycosylation endproducts precedes and correlates with early manifestations of renal and retinal disease in diabetes. Diabetes 44:824-829, 1995
11. Berg TJ, Bangstad HJ, Torjesen PA, Osterby R, Bucala R, Hanssen KF: Advanced glycation end products in serum predicts changes in the kidney morphology of patients with insulin-dependent diabetes mellitus. Metabolism 6:661-665, 1997
12. McCance DR, Dyer DG, Dunn JA, Bailie KE, Thorpe SE, Baynes JW, Lyons TJ: Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J Clin Invest 91:2470-2478, 1993
13. Cohen MP, Clements RS, Cohan JA, Shearman CW: Glycated albumin promotes a generalized vasculopathy in the db/db mouse. Biochem Biophys Res Comm 218:72-75, 1996
14. Cohen MP, Hud E, Wu V-Y: Amelioration of diabetic nephropathy by treatment with monoclonal antibodies against glycated albumin. Kidney Int 45:1673-1679, 1994
15. Ghigger GM, Candiano G, Delfino G, Bianchini F, Queirolo C: Glycosyl albumin and diabetic microalbuminuria: demonstration of an altered renal handling. Kidney Int 25:565-570, 1984
16. Cohen MP, Ziyadeh FN: Role of Amadori-modified nonenzymatically glycated serum proteins in the pathogenesis of diabetic nephropathy. J Am Soc Nephrol 7:183-190 1996
17. Clements RS Jr, Robison WG Jr, Cohen MP: Anti-glycated albumin therapy ameliorates early retinal microvascular pathology in db/db mice. J Diabetes Complications 12:28-33, 1998
18. Sakai H, Jinde K, Suzuki D, Yagame M, Nomoto Y: Localization of glycated proteins in the glomeruli of patients with diabetic nephropathy. Neprol Dial Transplant 11 (Suppl. 5):66-71, 1996
19. McLellan AC, Thornalley PJ: Synthesis and chromatography of 1,2-diamino-4,5-dimethoxybenzene, 6,7-dimethoxy-2-methylquinoxaline and 6,7,-dimethoxy-2,3-dimethylquinoxaline for use in a liquid chromatographic fluorimetric assay of methylglyoxal. Anal Chim Acta 253:137-142, 1992
20. Kato H, van Chuyen N, Shinoda T, Sekiya F, Hayase F: Metabolism of 3-deoxyglucosone, an intermediate compound in the Maillard reaction, administered orally or intravenously to rats. Biochem Biophys Acta 1035:71-76, 1990
21. Smulders RA, Stehouwer CDA, Schalkwijk CG, Donker AJM, Van Hinsbergh VWM, Te Koppele JM: Distinct association of HbA1c and the urinary excretion of pentosidine, an advanced glycosylation end-product, with endothelial function in insulin-dependent diabetes mellitus. Thromb Haemost 80:52-57, 1998
22. Reddy S, Bichler J, Wells-Knecht KJ, Thorpe SR, Baynes JW: N-(carboxy-methyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry 43:10872-10878, 1995
23. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, Poirier O, Danilov S, Parving H-H: Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 44:489-494, 1995
24. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976
25. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, Poirier O, Danilov S, Boelskifte S, Borch-Johnsen K: Insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy. Diabetologia 38:798-803, 1995
26. Brownlee M, Vlassara H, Kooney A, Ulrich P, Cerami A: Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 232:1629-1632, 1986
27. Coussons PJ, Jacoby J, McKay A, Kelly SM, Price NC, Hunt J: Glucose modification of human serum albumin: a structural study. Free Radic Biol Med 22:1217-1227, 1997
28. Edelstein D, Brownlee M: Mechanistic studies of advanced glycation end product inhibition by aminoguanidine. Diabetes 41:26-29, 1992
29. Armbruster DA: Fructosamine: structure, analysis and clinical usefulness. Clin Chem 33:2153-2163, 1987
30. Curtiss LK, Witztum JL: A novel method for generating region-specific monoclonal antibodies to modified proteins. J Clin Invest 72:1427-1438, 1983
31. Myint T, Hoshi S, Ookawara T, Miyazawa N, Suzuki K, Taniguchi N: Immunological detection of glycated proteins in normal and streptotocin-induced diabetic rats using anti-hexitol-lysine IgG. Biochem Biophys Acta 1271:73-79, 1995
32. Cohen M, Ziyadeh FN: Amadori glucose adducts modulate mesangial cell growth and collagen gene expression. Kidney Int 45:475-484, 1994
33. Makita Z, Vlassara H, Cerami A, Bucala R: Immunochemical detection of advanced glycosylation end products in vivo. J Biol Chem 267:5133-5138, 1992
34. Soulis Liparoto T, Cooper M, Papazoglou D, Clarke B, Jerums G: Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat. Diabetes 40:1328-1334, 1991
35. Hammes H, Martin S, Federlin K, Geisen K, Brownlee M: Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci U S A 88:11555-11558, 1991
36. Cameron NE, Cotter MA, Dines K, Love A: Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats. Diabetologia 35:946-950, 1992
37. Predescu D, Simionescu M, Simionescu N, Palade G: Binding and transcytosis of glycoalbumin by the microvascular endothelium of the myocardium: evidence that glycoalbumin behaves as a bifunctional ligand. J Cell Biol 107:1729-1738, 1988
38. Amore A, Cirina P, Mitola S, Peruzzi L, Gianoglio B, Rabbone I, Sachetti C, Cerutti F, Grillo C, Coppo R: Nonenzymatically glycated albumin (Amadori adducts) enhances nitric oxide synthase activity and gene expression in endothelial cells. Kidney Int 51:27-35, 1997
39. Ziyadeh FN, Han D-C, Cohen JA, Guo J, Cohen MP: Glycated albumin stimulates fibronectin gene expression in glomerular mesangial cells: involvement of the transforming growth factor-β system. Kidney Int 53:631-638, 1998